Yeliz Kaya1, Coskun Kaya2, Tuğba Kartal3, Tuğba Tahta4, Vehbi Y Tokgöz5. 1. Department of Gynecology and Obstetrics Nursing, Faculty of Health Sciences, Eskişehir Osmangazi University, Eskişehir, Turkey. 2. Department of Urology, Eskisehir City Hospital, Eskişehir, Turkey. 3. Eskişehir Osmangazi University Health, Practice and Research Hospital, Eskişehir, Turkey. 4. Health Services Vocational School, Ankara Medipol Üniversity, Ankara, Turkey. 5. Department of Gynecology and Obstetrics, Reproductive Endocrinology and Infertility, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.
Abstract
AIM: To show if lower urinary tract symptoms (LUTS) could be symptoms of COVID-19 with validated questionnaires. METHODS: The 96 COVID-19 patients who were hospitalised at a tertiary centre were collected retrospectively. After the exclusion criteria, 46 patients consisted the study population. All patients then fill formed the International Prostate Symptom Score and Urinary Symptom Profile respectively. All patients responded to these questions for the three period. RESULTS: Twenty-seven female (58.6%) and 19 male (41.4%) COVID-19 patients answered the questions. In the male patients, while there were no statistically significant differences in the total IPSS, the voiding IPSS score, and quality of life between the three periods (P = .148; P = .933, P = .079, respectively), the storage IPSS scores had a significant difference between the three periods (P = .05). In female patients, low stream scores were similar between the three periods (P = .368). The scores of stress incontinence and an overactive bladder had a significant difference between the three periods (P = .05 and P = .05). CONCLUSION: LUTS, especially storage symptoms, might be one of the initial symptoms of COVID-19 and the clinicians should evaluate LUTS with other known symptoms of the virus when a patient is suspected of having COVID-19.
AIM: To show if lower urinary tract symptoms (LUTS) could be symptoms of COVID-19 with validated questionnaires. METHODS: The 96 COVID-19patients who were hospitalised at a tertiary centre were collected retrospectively. After the exclusion criteria, 46 patients consisted the study population. All patients then fill formed the International Prostate Symptom Score and Urinary Symptom Profile respectively. All patients responded to these questions for the three period. RESULTS: Twenty-seven female (58.6%) and 19 male (41.4%) COVID-19patients answered the questions. In the male patients, while there were no statistically significant differences in the total IPSS, the voiding IPSS score, and quality of life between the three periods (P = .148; P = .933, P = .079, respectively), the storage IPSS scores had a significant difference between the three periods (P = .05). In female patients, low stream scores were similar between the three periods (P = .368). The scores of stress incontinence and an overactive bladder had a significant difference between the three periods (P = .05 and P = .05). CONCLUSION: LUTS, especially storage symptoms, might be one of the initial symptoms of COVID-19 and the clinicians should evaluate LUTS with other known symptoms of the virus when a patient is suspected of having COVID-19.
Authors: Laura E Lamb; Ryan Timar; Melissa Wills; Sorabh Dhar; Steve M Lucas; Dragana Komnenov; Michael B Chancellor; Nivedita Dhar Journal: Int Urol Nephrol Date: 2021-11-17 Impact factor: 2.266